CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

H Ling, R Spizzo, Yaser Atlasi, M Nicoloso, M Shinnizu, RS Redis, N Nishida, R Gafa, J Song, ZY Guo, C Ivan, E Barbarotto, I de Vries, XN Zhang, M Ferracin, M Churchman, Janneke Galen, BH Beverloo, M Shariati, F HaderkMR Estecio, G Garcia-Manero, GA Patijn, DC Gotley, V Bhardwaj, I Shureiqi, S Sen, AS Multani, J Welsh, K Yamamoto, I Taniguchi, MA Song, S Gallinger, G Casey, SN Thibodeau, L Le Marchand, M Tiirikainen, SA Mani, W Zhang, RV Davuluri, K Mimori, M Mori, Anieta Sieuwerts, John Martens, I Tomlinson, M Negrini, I Berindan-Neagoe, John Foekens, SR Hamilton, G Lanza, S Kopetz, Riccardo Fodde, GA Calin

Research output: Contribution to journalArticleAcademicpeer-review

553 Citations (Scopus)
30 Downloads (Pure)

Abstract

The functional roles of SNPs within the 8q24 gene desert in the cancer phenotype are not yet well understood. Here, we report that CCAT2, a novel long noncoding RNA transcript (IncRNA) encompassing the rs6983267 SNP, is highly over-expressed in microsatellite-stable colorectal cancer and promotes tumor growth, metastasis, and chromosomal instability. We demonstrate that MY, miR-17-5p, and miR-20a are up-regulated by CCAT2 through TCF7L2-mediated transcriptional regulation. We further identify the physical interaction between CC4T2 and TCF7L2 resulting in an enhancement of WNT signaling activity. We show that CCAT2 is itself a WNT downstream target, which suggests the existence of a feedback loop. Finally, we demonstrate that the SNP status affects CC4T2 expression and the risk allele G produces more CCAT2 transcript. Our results support a new mechanism of MYC and WNT regulation by the novel IncRNA CCAT2 in colorectal cancer pathogenesis, and provide an alternative explanation of the SNP-conferred cancer risk.
Original languageUndefined/Unknown
Pages (from-to)1446-1461
Number of pages16
JournalGenome Research
Volume23
Issue number9
DOIs
Publication statusPublished - 2013

Research programs

  • EMC MM-03-24-01
  • EMC MM-03-86-01

Cite this